Ibex Medical Analytics

We're feeling energized after the impressive Wales Digital Pathology & AI Reporting Workshop today! This hands-on session allowed NHS pathologists to gain first-hand experience using Ibex's AI as they reviewed several cancer cases digitally on Barco screens. Thank you to Dr. Muhammad Aslam, Dr. Anu Gunavardhan, the team at Betsi Cadwaladr University Health Board & the Royal College of Pathologists (RCPath) for putting on this impactful event and continuing to lead the way in #digitalpathology and #AI-powered cancer diagnostics! NHS Wales #cancerdiagnostics #pathology Richard Nicholson Leigh-Anne Mcduffus Daniel Ignatov

This week, several Boston Ibexers joined the Boston Health Care for the Homeless Program for bingo! BHCHP has been a pillar in the Boston health care community for 40 years now, and we're consistently inspired by their work and the impact they're having on our city. You can learn more about BHCHP's mission and how you can support here: https://lnkd.in/eei5ar9n Thank you to Edith Gregory and Rachel Broderick for organizing! #healthcare

We're just a few weeks away from #USCAP2025 & the Ibex team is excited to welcome everyone to Boston, our US headquarters! We'll be at booth #929 offering live demos of the Ibex platform, the most widely deployed AI platform for cancer diagnostics and trusted by pathologists around the world. View our robust clinical program and schedule your demo today: https://lnkd.in/esU6mT76 USCAP - United States and Canadian Academy of Pathology #pathology #USCAP #digitalpathology #cancerdiagnostics

Next week we'll be in Paris for the 1ère Journée IA et Pathologie, Société Fran?aise de Pathologie! Stop by our booth for a live demo of Ibex's Platform, the most widely deployed AI in pathology and trusted by pathologists around the world. Schedule time with our team here: https://lnkd.in/ekPX2ZuW Geraldine Sebag Emmanuelle Stebe Cees Smit #pathology #AI #digitalpathology #cancerdiagnostics

ICYMI earlier this month we announced that Ibex received our first FDA 510(k) clearance! This milestone validates the safety and effectiveness of our #AIpowered solution and strengthens our commitment to delivering cutting-edge innovation to #pathologists. Through robust precision and clinical validation studies conducted during the FDA clearance process, Ibex Prostate Detect identified a 13% rate of missed cancers in patients initially diagnosed as benign. This underscores the critical role of our technology as a safety net for pathologists, ensuring patients receive an accurate cancer diagnosis. To learn more, visit the link in the comments. #AI #Pathology #ProstateCancer #Diagnostics #FDAClearance

"Anything we can do to alleviate concern and get answers into patient and clinicians hands quicker, and actually get the correct answers with the highest possible quality, is what Alverno has always been about" says Sam Terese, Alverno Laboratories CEO on why they chose to use Ibex's #AI platform. Learn how Alverno is using our #AI-powered tools help reduce turnaround times and deliver the highest quality #diagnostics to their patients in the video below. #pathology #healthcareAI #cancercare #digitalpathology

In a KLAS Research Performance Report, 100% of Ibex customers saw outcomes with 6 months. We're honored to support pathologists around the world with our #AI-powered tools that assist with #cancer diagnosis. Review the complete report for more direct feedback from our customers: https://lnkd.in/eTsYPfCY #digitalpathology #pathology #cancerdiagnostics

Thank you, Jordyn Sava at Targeted Oncology for highlighting Ibex’s recent FDA 510(k) clearance for Ibex Prostate Detect! We’re excited to announce FDA 510(k) clearance for our AI-powered digital pathology solution, designed to identify small and rare prostate cancers. As CEO Joseph (Yossi) Mossel states, “We hope this accomplishment will bolster industry-wide confidence that AI-powered digital pathology is ready for widespread clinical adoption.” This milestone is just the beginning, and we’re eager to help advance treatments and improve patient outcomes with our innovative AI platform. Read the full article here: https://lnkd.in/ebBNUaFG #AI #DigitalPathology #ProstateCancer #FDAclearance

Did you know that 1 in 8 men will be diagnosed with prostate cancer during their lifetime? With early diagnosis and treatment, prostate cancer is often highly curable. We're thrilled to receive FDA 510(k) Clearance for Ibex Prostate Detect, the first FDA cleared device that provides AI-powered heatmaps for all areas with likelihood for cancer. This milestone validates the safety and effectiveness of our #AIpowered solution and strengthens our commitment to delivering cutting-edge innovation to #pathologists. Link to the press release in the comments below ?? #digitalpathology #cancer #pathology #prostatecancer #cancerdiagnostics

AI-powered cancer diagnostics company Ibex Medical Analytics won FDA 510(k) clearance for Ibex Prostate Detect, an in vitro diagnostic #medicaldevice that harnesses AI to generate heatmaps identifying small and rare missed prostatic cancers. ?? “This clearance affirms our commitment to the safety and efficacy of our AI solutions and strengthens our ability to provide cutting-edge innovation to pathologists, which ultimately benefit patients," shared CEO Joseph (Yossi) Mossel. Read more: https://lnkd.in/dvF5BV-b ?? Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dEEdqWAQ #MedicalDevices #MedicalEquipment #HealthTech #Headhunter #GuidedSolutions #ExecutiveSearch #MedTechExecutiveSearch